The International Pharmacopoeia
The International Pharmacopoeia is an essential point of
reference for anyone involved in the research, development or manufacture of
medicines. The contents shall have legal status, whenever a national or
regional authority expressly introduces it into appropriate legislation.
The pharmacopoeia consists of quality specifications for
pharmaceutical substances and dosage forms together with supporting general
methods of analysis. These features are intended to serve as source material
for reference or adaptation by any World Health Organization (WHO) Member State
wishing to establish pharmaceutical requirements.
Author: World Health
Organization (WHO)
Publisher: WHO
The International Pharmacopoeia CD-ROM - 5th
edition - Front
The International Pharmacopoeia, or any part of it,
shall have legal status, whenever a national or regional authority expressly
introduces it into appropriate legislation.
The International Pharmacopoeia (Ph. Int.) is
published by WHO with the aim to achieve a wide global harmonization of quality
specifications for selected pharmaceutical products, excipients and dosage forms.
The activities related to the International Pharmacopoeia
are an essential element in overall quality control and assurance of
pharmaceuticals contributing to the safety and efficacy of medicines. The work
on The International Pharmacopoeia is carried out in collaboration with members
of the WHO Expert Advisory Panel on The International Pharmacopoeia and WHO
Expert Committee on Specification for Pharmaceutical Preparations and with
other specialists. The process involves consultation of and input from WHO
Member States' drug regulatory authorities and national drug quality control
laboratories, WHO collaborating Centres, standard-setting organizations and
with manufacturers around the world.
No comments:
Post a Comment